About Viatris, Inc. 
Viatris, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 125 Schemes (40.97%)
Foreign Institutions
Held by 373 Foreign Institutions (14.17%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
3,581 Million
(Quarterly Results - Jun 2025)
Net Profit:
-5 Million
Pharmaceuticals & Biotechnology
USD 12,476 Million (Small Cap)
38.00
NA
104.18%
0.89
1.79%
0.80






